glp-1 and afib Glucagon-like peptide 1 receptor agonists: cardiovascular benefits mechanisms of action Abstract 4368472: Glucagon-Like Peptide 1
Description
Nutrients, 13(4), 1317
Specific antagonists were given 2 h before glucose at 1,500 nmol kg 1 doses, and tirzepatide was given 1 h before glucose, all by intraperitoneal injection
Hunger isnt the enemy
Data Availability Statement Data sharing is not applicable as no new data were generated
